The road to recovery after a bone marrow transplant can be complicated by cytopenia(s) - when one or more of your blood cell types is lower than normal. Sometimes, this is “immune-mediated,” meaning your red cells or platelets are being targeted and destroyed by the body's immune system. NHLBI researchers are testing the drug fostamatinib in adults with immune-mediated cytopenia(s) to see if it will help. The study enrolls adults who are ≥ 60 days post-transplant, experiencing hard-to-treat cytopenia(s), and are transfusion dependent. If you know someone who qualifies, contact the NIH Clinical Center Office of Patient Recruitment at 866-444-2214 (TTY users dial 7-1-1), ccopr@nih.gov or visit https://bit.ly/3Vh6ZUP. Ask for study #000758-H.
A research study at the National Heart, Lung, and Blood Institute is looking for pregnant women with sickle cell disease between 18 and 45 years of age who are at risk of having an infant with sickle cell disease to donate their baby's cord blood. Tests and procedures provided at no cost. Contact the NIH Clinical Center Office of Patient Recruitment at 866-444-2214 (TTY users dial 7-1-1), ccopr@nih.gov or visit https://go.usa.gov/xSQqW. Refer to study #01-H-0122.
NIAID researchers enroll healthy volunteers 18-29 living in the DC, Maryland, and Virginia areas in an investigational Epstein-Barr virus (EBV) vaccine clinical trial. If you are eligible, consider joining to help research into stopping the spread of EBV —the most common cause of infectious mononucleosis (mono) and associated with some cancers. Compensation will be provided, up to $2220 over the course of the trial. For more information, contact the NIH Clinical Center Office of Patient Recruitment at 866-444-2214 (TTY users dial 7-1-1) or ccopr@nih.gov or visit https://go.usa.gov/xsYK5. Refer to study #21-I-0005.
